Balance Sheet
Cash Flow Statement
Amortization of GoodwillAmortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Onconetix (ONCO) Depreciation & Amortization (CF) (2023 - 2025)

Historic Depreciation & Amortization (CF) for Onconetix (ONCO) over the last 3 years, with Q3 2025 value amounting to $3387.0.

  • Onconetix's Depreciation & Amortization (CF) fell 9834.01% to $3387.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $131133.0, marking a year-over-year decrease of 7985.97%. This contributed to the annual value of $731345.0 for FY2024, which is 156453.1% up from last year.
  • Latest data reveals that Onconetix reported Depreciation & Amortization (CF) of $3387.0 as of Q3 2025, which was down 9834.01% from $3699.0 recorded in Q2 2025.
  • Onconetix's 5-year Depreciation & Amortization (CF) high stood at $206700.0 for Q1 2024, and its period low was $1571.0 during Q2 2023.
  • Its 3-year average for Depreciation & Amortization (CF) is $71556.0, with a median of $4748.0 in 2025.
  • As far as peak fluctuations go, Onconetix's Depreciation & Amortization (CF) skyrocketed by 1271355.82% in 2024, and later plummeted by 9834.01% in 2025.
  • Over the past 3 years, Onconetix's Depreciation & Amortization (CF) (Quarter) stood at $39051.0 in 2023, then skyrocketed by 205.5% to $119299.0 in 2024, then tumbled by 97.16% to $3387.0 in 2025.
  • Its last three reported values are $3387.0 in Q3 2025, $3699.0 for Q2 2025, and $4748.0 during Q1 2025.